PerkinElmer, Inc. Launches New EnSpire(TM) Multilabel Plate Readers with Luminescence Capability, for Primary and Stem Cell Research

CHICAGO--(BUSINESS WIRE)--Neuroscience 2009 – PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today launched the latest expansion of the EnSpire™ Multilabel Plate Reader platform - EnSpire, with ultra sensitive luminescence detection. This new detection capability provides scientists, including those working with primary or stem cells in cancer and neuropharmacology research, with enhanced capabilities to improve assay performance and sensitivity.

MORE ON THIS TOPIC